IGF2BP2 and acute lymphoblastic leukemia: Furthermore, IGF2BP2 reduces apoptosis induced by chemotherapeutic agents such as acitretin, vincristine, vannamei, or dexamethasone, contributing to chemoresistance in T-ALL (211).